IMPORTANCE: Alterations in glutamatergic neurotransmission have been postulated to be a key pathophysiologic mechanism in schizophrenia. OBJECTIVE: To evaluate hippocampal volumetric measures and neurometabolites in unmedicated patients with schizophrenia and the correlations between these markers. Our a priori hypothesis was that glutamate levels would negatively correlate with hippocampal volume in schizophrenia. DESIGN, SETTING, AND PARTICIPANTS: Combined 3-T structural magnetic resonance imaging and single-voxel proton magnetic resonance spectroscopy study at the Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, of 27 unmedicated patients with schizophrenia and 27 healthy controls. MAIN OUTCOMES AND MEASURES: Hippocampal volumetric measures and neurometabolites, and the correlations between volumetric measurements and neurometabolites. RESULTS: Hippocampal volumetric deficits, increased ratios of hippocampal glutamate and glutamine to creatine (Glx/Cr), and a loss of correlation between hippocampal N-acetylaspartate (NAA)/Cr and Glx/Cr in patients with schizophrenia were found. Significant correlations between hippocampal volumetric measures and Glx/Cr were also found in patients with schizophrenia but not healthy controls. CONCLUSIONS AND RELEVANCE: Our findings support the theory that alterations in hippocampal glutamate levels potentially account for structural deficits in the hippocampus observed in schizophrenia neuroimaging studies.
IMPORTANCE: Alterations in glutamatergic neurotransmission have been postulated to be a key pathophysiologic mechanism in schizophrenia. OBJECTIVE: To evaluate hippocampal volumetric measures and neurometabolites in unmedicated patients with schizophrenia and the correlations between these markers. Our a priori hypothesis was that glutamate levels would negatively correlate with hippocampal volume in schizophrenia. DESIGN, SETTING, AND PARTICIPANTS: Combined 3-T structural magnetic resonance imaging and single-voxel proton magnetic resonance spectroscopy study at the Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, of 27 unmedicated patients with schizophrenia and 27 healthy controls. MAIN OUTCOMES AND MEASURES: Hippocampal volumetric measures and neurometabolites, and the correlations between volumetric measurements and neurometabolites. RESULTS: Hippocampal volumetric deficits, increased ratios of hippocampal glutamate and glutamine to creatine (Glx/Cr), and a loss of correlation between hippocampal N-acetylaspartate (NAA)/Cr and Glx/Cr in patients with schizophrenia were found. Significant correlations between hippocampal volumetric measures and Glx/Cr were also found in patients with schizophrenia but not healthy controls. CONCLUSIONS AND RELEVANCE: Our findings support the theory that alterations in hippocampal glutamate levels potentially account for structural deficits in the hippocampus observed in schizophrenia neuroimaging studies.
Authors: Ludger Tebartz van Elst; Gabi Valerius; Martin Büchert; Thorsten Thiel; Nicholas Rüsch; Emanuel Bubl; Jürgen Hennig; Dieter Ebert; Hans M Olbrich Journal: Biol Psychiatry Date: 2005-07-14 Impact factor: 13.382
Authors: S E Arnold; B R Franz; R C Gur; R E Gur; R M Shapiro; P J Moberg; J Q Trojanowski Journal: Am J Psychiatry Date: 1995-05 Impact factor: 18.112
Authors: Kevin W Waddell; Parham Zanjanipour; Subechhya Pradhan; Lei Xu; Edward B Welch; James M Joers; Peter R Martin; Malcolm J Avison; John C Gore Journal: Magn Reson Imaging Date: 2010-09-29 Impact factor: 2.546
Authors: A Bertolino; S Nawroz; V S Mattay; A S Barnett; J H Duyn; C T Moonen; J A Frank; G Tedeschi; D R Weinberger Journal: Am J Psychiatry Date: 1996-12 Impact factor: 18.112
Authors: Scott A Schobel; Nicole M Lewandowski; Cheryl M Corcoran; Holly Moore; Truman Brown; Dolores Malaspina; Scott A Small Journal: Arch Gen Psychiatry Date: 2009-09
Authors: Eric Plitman; Shinichiro Nakajima; Camilo de la Fuente-Sandoval; Philip Gerretsen; M Mallar Chakravarty; Jane Kobylianskii; Jun Ku Chung; Fernando Caravaggio; Yusuke Iwata; Gary Remington; Ariel Graff-Guerrero Journal: Eur Neuropsychopharmacol Date: 2014-08-01 Impact factor: 4.600
Authors: Petr Bednařík; Amir Moheet; Dinesh K Deelchand; Uzay E Emir; Lynn E Eberly; Martin Bareš; Elizabeth R Seaquist; Gülin Öz Journal: NMR Biomed Date: 2015-04-22 Impact factor: 4.044
Authors: Eric Plitman; Raihaan Patel; Jun Ku Chung; Jon Pipitone; Sofia Chavez; Francisco Reyes-Madrigal; Gladys Gómez-Cruz; Pablo León-Ortiz; M Mallar Chakravarty; Camilo de la Fuente-Sandoval; Ariel Graff-Guerrero Journal: Neuropsychopharmacology Date: 2016-06-08 Impact factor: 7.853
Authors: Eric Plitman; Yusuke Iwata; Fernando Caravaggio; Shinichiro Nakajima; Jun Ku Chung; Philip Gerretsen; Julia Kim; Hiroyoshi Takeuchi; M Mallar Chakravarty; Gary Remington; Ariel Graff-Guerrero Journal: Schizophr Bull Date: 2017-07-01 Impact factor: 9.306
Authors: Paul E Croarkin; M Albert Thomas; John D Port; Joshua M Baruth; Doo-Sup Choi; Osama A Abulseoud; Mark A Frye Journal: Bipolar Disord Date: 2014-12-12 Impact factor: 6.744
Authors: S Andrea Wijtenburg; Susan N Wright; Stephanie A Korenic; Frank E Gaston; Nkemdilim Ndubuizu; Joshua Chiappelli; Robert P McMahon; Hongji Chen; Anya Savransky; Xiaoming Du; Danny J J Wang; Peter Kochunov; L Elliot Hong; Laura M Rowland Journal: Neuropsychopharmacology Date: 2016-08-26 Impact factor: 7.853